Patents by Inventor James David Pancook

James David Pancook has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CHIMERIC CANINE ANTI-CD20 ANTIBODY
    Publication number: 20230257476
    Abstract: The disclosure relates to caninized chimeric anti-CD20 antibodies to the canine protein CD20 and methods of use to treat certain disorders such as non-Hodgkins B-cell lymphoma in dogs.
    Type: Application
    Filed: April 20, 2023
    Publication date: August 17, 2023
    Inventor: James David PANCOOK
  • Variants of human BMP7 protein
    Patent number: 11466066
    Abstract: The present invention relates to novel variants of human BMP7 protein. The invention embodies vectors and host cells for the propagation of nucleic acid sequences encoding said proteins and the production thereof. Also disclosed are methods for the treatment of cancer, cartilage damage and degeneration, pain associated with osteoarthritis, or bone healing.
    Type: Grant
    Filed: April 20, 2018
    Date of Patent: October 11, 2022
    Assignee: ELI LILLY AND COMPANY
    Inventors: James David Pancook, Scott William Rowlinson, Louis Frank Stancato
  • TIGIT AND PD-1/TIGIT-BINDING MOLECULES
    Publication number: 20220227860
    Abstract: The present invention relates to polypeptide molecules that bind to human TIGIT, and to polypeptide molecules that bind to human PD-1 and human TIGIT, and are useful for treating solid tumors, alone and in combination with chemotherapy and/or ionizing radiation.
    Type: Application
    Filed: May 22, 2020
    Publication date: July 21, 2022
    Inventors: Yiqing FENG, Naresh KUMAR, James David PANCOOK, Stephanie Marie TRUHLAR, Yang ZHAO
  • NEUREGULIN-4 COMPOUNDS AND METHODS OF USE
    Publication number: 20220112255
    Abstract: The present invention relates to neuregulin (NRG) 4 compounds and methods of treatment with NRG4 compounds.
    Type: Application
    Filed: December 22, 2021
    Publication date: April 14, 2022
    Inventors: Jonathan Wesley Day, Josef George Heuer, Avinash Muppidi, Wei Ni, James David Pancook
  • Neuregulin-4 compounds and methods of use
    Patent number: 11242370
    Abstract: The present invention relates to neuregulin (NRG) 4 compounds and methods of treatment with NRG4 compounds.
    Type: Grant
    Filed: March 31, 2020
    Date of Patent: February 8, 2022
    Assignee: Eli Lilly and Company
    Inventors: Jonathan Wesley Day, Josef George Heuer, Avinash Muppidi, Wei Ni, James David Pancook
  • CHIMERIC CANINE ANTI-CD20 ANTIBODY
    Publication number: 20210163618
    Abstract: The disclosure relates to caninized chimeric anti-CD20 antibodies to the canine protein CD20 and methods of use to treat certain disorders such as non-Hodgkins B-cell lymphoma in dogs.
    Type: Application
    Filed: February 4, 2021
    Publication date: June 3, 2021
    Inventor: James David Pancook
  • VARIANTS OF HUMAN BMP7 PROTEIN
    Publication number: 20210115100
    Abstract: The present invention relates to novel variants of human BMP7 protein. The invention embodies vectors and host cells for the propagation of nucleic acid sequences encoding said proteins and the production thereof. Also disclosed are methods for the treatment of cancer, cartilage damage and degeneration, pain associated with osteoarthritis, or bone healing.
    Type: Application
    Filed: April 20, 2018
    Publication date: April 22, 2021
    Inventors: James David Pancook, Scott William Rowlinson, Louis Frank Stancato
  • Chimeric canine anti-CD20 antibody
    Patent number: 10941206
    Abstract: The disclosure relates to caninized chimeric anti-CD20 antibodies to the canine protein CD20 and methods of use to treat certain disorders such as non-Hodgkins B-cell lymphoma in dogs.
    Type: Grant
    Filed: November 14, 2019
    Date of Patent: March 9, 2021
    Assignee: Elanco US Inc.
    Inventor: James David Pancook
  • NEUREGULIN-4 COMPOUNDS AND METHODS OF USE
    Publication number: 20200354421
    Abstract: The present invention relates to neuregulin (NRG) 4 compounds and methods of treatment with NRG4 compounds.
    Type: Application
    Filed: March 31, 2020
    Publication date: November 12, 2020
    Inventors: Jonathan Wesley Day, Josef George Heuer, Avinash Muppidi, Wei NI, James David Pancook
  • CHIMERIC CANINE ANTI-CD20 ANTIBODY
    Publication number: 20200131273
    Abstract: The disclosure relates to caninized chimeric anti-CD20 antibodies to the canine protein CD20 and methods of use to treat certain disorders such as non-Hodgkins B-cell lymphoma in dogs.
    Type: Application
    Filed: November 14, 2019
    Publication date: April 30, 2020
    Inventor: James David Pancook
  • Chimeric canine anti-CD20 antibody
    Patent number: 10519244
    Abstract: The disclosure relates to caninized chimeric anti-CD20 antibodies to the canine protein CD20 and methods of use to treat certain disorders such as non-Hodgkins B-cell lymphoma in dogs.
    Type: Grant
    Filed: February 10, 2017
    Date of Patent: December 31, 2019
    Assignee: Elanco US Inc.
    Inventor: James David Pancook
  • CHIMERIC CANINE ANTI-CD20 ANTIBODY
    Publication number: 20190194342
    Abstract: The disclosure relates to caninized chimeric anti-CD20 antibodies to the canine protein CD20 and methods of use to treat certain disorders such as non-Hodgkins B-cell lymphoma in dogs.
    Type: Application
    Filed: February 10, 2017
    Publication date: June 27, 2019
    Applicant: Elanco US Inc.
    Inventor: James David PANCOOK
  • TGF-beta binding antibodies
    Patent number: 7927593
    Abstract: The present invention provides very high affinity antibodies, or antigen-binding fragments thereof, that neutralize mature human TGF-?1, TGF-?2, and TGF-?3. The antibodies of the invention are useful for treating cell proliferative disorders in a mammal.
    Type: Grant
    Filed: January 26, 2010
    Date of Patent: April 19, 2011
    Assignee: Eli Lilly and Company
    Inventors: Bryan Edward Jones, James David Pancook, Scott William Rowlinson